|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/12 | |
| C12N 7/00 |
| (11) | Patento numeris | 2968515 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14717940.2 |
| Europos patento paraiškos padavimo data | 2014-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/026570 |
| Data | 2014-03-13 |
| (87) | Numeris | WO 2014/151855 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361784122 P | 2013-03-14 | US |
| (72) |
STINCHCOMB, Dan T., US
LIVENGOOD, Jill A., US
VARGA, Laszlo, US
|
| (73) |
Takeda Vaccines, Inc.,
75 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS |
| COMPOSITIONS AND METHODS FOR LIVE, ATTENUATED ALPHAVIRUS FORMULATIONS |